Ignite Creation Date:
2025-12-24 @ 3:58 PM
Ignite Modification Date:
2026-04-07 @ 6:57 PM
Study NCT ID:
NCT06910592
Status:
COMPLETED
Last Update Posted:
2025-09-17
First Post:
2025-03-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EXOMIND (BTL-995) for Reduction of Binge-eating
Sponsor:
BTL Industries Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BTL-995_CTBG100
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None